Shopping Cart
- Remove All
Your shopping cart is currently empty
Pagibaximab, a chimeric IgG1 antibody, targets the lipoteichoic acid on the surfaces of S. aureus and S. epidermidis, and is utilized for the prevention of staphylococcal sepsis [1].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | 2-4 weeks | |
| 5 mg | $622 | 2-4 weeks | |
| 10 mg | $1,050 | 2-4 weeks |
| Description | Pagibaximab, a chimeric IgG1 antibody, targets the lipoteichoic acid on the surfaces of S. aureus and S. epidermidis, and is utilized for the prevention of staphylococcal sepsis [1]. |
| Molecular Weight | 146.07 (kDa) |
| Cas No. | 595566-61-3 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.